Evidence map›Paper›PMID 23954916›Full record

ReviewPediatric nephrology (Berlin, Germany)2014

Bone morphogenetic protein signaling in nephron progenitor cells.

Leif Oxburgh, Aaron C Brown, Sree Deepthi Muthukrishnan, Jennifer L Fetting

Abstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Mesangial cell - the glomerular stromal cell.Nature reviews. Nephrology · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. BMP signaling and its modifiers in kidney development.Pediatric nephrology (Berlin, Germany) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Leif OxburghDepartment of Molecular Medicine, Maine Medical Center Research Institute, 81 Research Drive, Scarborough, ME, 04106, USA, oxburl@mmc.org.
Aaron C Brown
Sree Deepthi Muthukrishnan
Jennifer L Fetting
Maine Medical Center · USMaine Medical Center Research Institute · US

Funding

Defining the progenitor cell niche of the developing kidneyR01DK078161 · NIDDK · MAINEHEALTH · PI OXBURGH, LEIF · 2008 to 2016
$3.4M
Transcriptional control of mesangial cell differentiationF32DK093196 · NIDDK · MAINEHEALTH · PI FETTING, JENNIFER · 2011 to 2014
$167k
NIDDK NIH HHS F32 DK093196NIDDK NIH HHS F32DK093196NIDDK NIH HHS R01 DK078161NIDDK NIH HHS R01DK078161
6 · The paper itself

Abstract

Bone morphogenetic protein (BMP) signaling plays an essential role in many aspects of kidney development, and is a major determinant of outcome in kidney injury. BMP treatment is also an essential component of protocols for differentiation of nephron progenitors from pluripotent stem cells. This review discusses the role of BMP signaling to nephron progenitor cells in each of these contexts.

Indexed as

AnimalsBone Morphogenetic ProteinsHumansNephronsOrganogenesisSignal TransductionStem CellsBone Morphogenetic Proteins

Identifiers

PMID23954916
PMCPMC3944211
OpenAlexW2016566634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.